APLS - Apellis Pharmaceuticals, Inc.
20.15
0.290 1.439%
Share volume: 2,925,778
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$19.86
0.29
0.01%
Summary score
46%
Profitability
36%
Dept financing
36%
Liquidity
75%
Performance
50%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-9.06%
Return on sales
-253.54%
Return on invested capital
0%
Total debt ratio
69.42%
Debt ratio change over timeo
0%
Current Ratio
4.96%
Quick Ratio
4.41%
Cash Position Ratio
2.88%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
0.48%
Return on sales
-11.38%
Return on invested capital
0%
Total debt ratio
72.08%
Debt ratio change over timeo
0%
Current Ratio
3.63%
Quick Ratio
3.15%
Cash Position Ratio
1.75%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-4.77%
Return on sales
-25.58%
Return on invested capital
0%
Total debt ratio
65.58%
Debt ratio change over time
0%
Current Ratio
3.14%
Quick Ratio
2.7%
Cash Position Ratio
1.44%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | APLS | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 12.23% | 10.41% | 0% |
| Return on assets | -9.06% | 4.74% | 3.19% | 1.73% |
| Return on sales | -253.54% | 30.88% | 25.28% | 24.06% |
| Return on invested capital | 0% | 8.04% | 10.95% | 0% |
| Profitability | 0% | 93% | 84% | 29% |
| Total debt ratio | 69.42% | 80.37% | 59.38% | 94.09% |
| Debt ratio change over time | 0% | -20.57% | -85.61% | 17.33% |
| Dept financing | 18% | 21% | 16% | 50% |
| Current Ratio | 3.63% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 3.15% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 1.75% | 0.16% | 0.44% | 0.14% |
| Liquididy | 75% | 13% | 15% | 10% |
| Short-term ratios | APLS | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 0.48% | 6.06% | 4.18% | 1.7% |
| Return on sales | -11.38% | 39.61% | 26.91% | 24.78% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 52% | 50% | 34% | 23% |
| Total debt ratio | 72.08% | 80% | 59.26% | 100.88% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 43% | 20% | 15% | 25% |
| Current Ratio | 3.63% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 3.15% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 1.75% | 0.16% | 0.44% | 0.14% |
| Liquididy | 75% | 21% | 20% | 12% |